Application

18836576 · PHARMACEUTICAL COMPOSITIONS COMPRISING A 225-ACTINIUM-LABELLED COMPLEX AND A BISMUTH SEQUESTERING AGENT

Filed 2024-08-07 · Pending The official file ↗ · Art unit 6211 · Examiner Patricia A Leith Hard · CPC A61K 51/0497 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

24.8 mo

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.